Rna-seq analysis of enteroendocrine cells reveals a role for fabp5 in the control of gip secretion

Molecular Endocrinology

Volumn 28, Issue 11, 2014, Pages 1855-1865

  Sommer, Cesar A ^a   Mostoslavsky, Gustavo ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ENDOCANNABINOID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; GASTRIC INHIBITORY POLYPEPTIDE; GREEN FLUORESCENT PROTEIN; NEUROGENIN 3; TRANSCRIPTOME; UNCLASSIFIED DRUG; FABP5 PROTEIN, MOUSE; RNA; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; ENTEROENDOCRINE CELL; GENE EXPRESSION; HORMONE RELEASE; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; RNA SEQUENCE; SEQUENCE ANALYSIS; ANIMAL; DIET; DIET RESTRICTION; GENETICS; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLISM; OBESITY; PROCEDURES; PROMOTER REGION; SMALL INTESTINE;

ANIMALS; DIET; ENDOCANNABINOIDS; ENTEROENDOCRINE CELLS; FASTING; FATTY ACID-BINDING PROTEINS; GASTRIC INHIBITORY POLYPEPTIDE; GREEN FLUORESCENT PROTEINS; INSULIN RESISTANCE; INTESTINE, SMALL; METABOLIC DISEASES; MICE; NEOPLASM PROTEINS; OBESITY; PROMOTER REGIONS, GENETIC; RNA; SEQUENCE ANALYSIS, RNA;

EID: 84908317608     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1194     Document Type: Article

References (44)

1. Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature. 2006;444:854–859.
2. Wang J, Cortina G, Wu SV, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med. 2006;355:270–280.
3. Mellitzer G, Beucher A, Lobstein V, et al. Loss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival. J Clin Invest. 2010;120:1708–1721.
4. Roth KA, Kim S, Gordon JI. Immunocytochemical studies suggest two pathways for enteroendocrine cell differentiation in the colon. Am J Physiol. 1992;263:G174–G180.
5. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: a primary cell study. Cell Metab. 2008;8:532–539.
6. Liou AP, Sei Y, Zhao X, et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol. 2011;300:G538–G546.
7. Egerod KL, Engelstoft MS, Grunddal KV, et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153: 5782–5795.
8. Habib AM, Richards P, Cairns LS, et al. Overlap of endocrine hormone expression in the mouse intestine revealed by transcrip-tional profiling and flow cytometry. Endocrinology. 2012;153: 3054–3065.
9. Schirra J, Katschinski M, Weidmann C, et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest. 1996;97:92–103.
10. Tseng CC, Jarboe LA, Wolfe MM. Regulation of glucose-dependent insulinotropic peptide gene expression by a glucose meal. Am J Physiol. 1994;266:G887–G891.
11. Ross SA, Dupre J. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Diabetes. 1978; 27:327–333.
12. Flatt PR, Bailey CJ, Kwasowski P, Swanston-Flatt SK, Marks V. Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice. Diabetes. 1983;32:433–435.
13. Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002;8:738–742.
14. Creutzfeldt W, Ebert R, Willms B, Frerichs H, Brown JC. Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia. 1978;14:15-24.
15. Salera M, Giacomoni P, Pironi L, et al. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. J Clin Endocrinol Metab. 1982;55: 329-336.
16. Timper K, Grisouard J, Sauter NS, et al. Glucose-dependent insuli-notropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes. Am J Physiol Endocrinol Metab. 2013;304:E1-E13.
17. Althage MC, Ford EL, Wang S, Tso P, Polonsky KS, Wice BM. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem. 2008;283:18365-18376.
18. Maeda K, Uysal KT, Makowski L, et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes. 2003;52:300-307.
19. Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7:562-578.
20. Thorvaldsdóttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178-192.
21. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262-265.
22. Sei Y, Lu X, Liou A, Zhao X, Wank SA. A stem cell marker-expressing subset of enteroendocrine cells resides at the crypt base in the small intestine. Am J Physiol Gastrointest Liver Physiol. 2011;300:G345-G356.
23. Buczacki SJ, Zecchini HI, Nicholson AM, et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature. 2013;495:65-69.
24. Bjerknes M, Cheng H. Neurogenin 3 and the enteroendocrine cell lineage in the adult mouse small intestinal epithelium. Dev Biol. 2006;300:722-735.
25. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5:621-628.
26. Suzuki K, Harada N, Yamane S, et al. Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity. J Biol Chem. 2013;288: 1929-1938.
27. Moss CE, Marsh WJ, Parker HE, et al. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents. Diabetologia. 2012;55:3094-3103.
28. Chu ZL, Carroll C, Alfonso J, et al. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology. 2008;149:2038-2047.
29. Wang Y, Chandra R, Samsa LA, et al. Amino acids stimulate cho-lecystokinin release through the Ca2 +-sensing receptor. Am J Physiol Gastrointest Liver Physiol. 2011;300:G528-G537.
30. Nozawa K, Kawabata-Shoda, Doihara H, et al. TRPA1 regulates gastrointestinal motility through serotonin release from entero-chromaffin cells. Proc Natl Acad Sci USA. 2009;106:3408-3413.
31. Essand M, Vikman S, Grawé J, et al. Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1. JMol Endocrinol. 2005;35:489-501.
32. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7:489–503.
33. Matsumata M, Sakayori N, Maekawa M, Owada Y, Yoshikawa T, Osumi N. The effects of Fabp7 and Fabp5 on postnatal hippocam-pal neurogenesis in the mouse. Stem Cells. 2012;30:1532–1543.
34. Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology. 2004;145:2639–2644.
35. Kaczocha M, Glaser ST, Deutsch DG. Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA. 2009;106:6375–6380.
36. Berger WT, Ralph BP, Kaczocha M, et al. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. PLoS One. 2012;7:e50968.
37. DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D. Endocan-nabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci USA. 2011;108:12904–12908.
38. Gómez R, Navarro M, Ferrer B, et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci. 2002;22:9612-9617.
39. Fujita Y, Wideman RD, Asadi A, et al. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet a-cells and promotes insulin secretion. Gastroenterology. 2010;138:1966-1975.
40. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17:819-837.
41. Sykaras AG, Demenis C, Case RM, McLaughlin JT, Smith CP. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocan-nabinoid and fatty acid receptors. PLoS One. 2012;7:e42373.
42. Brubaker PL. A beautiful cell (or two or three?). Endocrinology. 2012;153:2945-2948.
43. Yu S, Levi L, Siegel R, Noy N. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome pro-liferator-activated receptor /3/S (PPAR/3/S).JBiol Chem. 2012;287: 42195-42205.
44. Neeli I, Siddiqi SA, Siddiqi S, et al. Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum. J Biol Chem. 2007;282:17974-17984.